Senti Biosciences (SNTI) Misses Q1 EPS by 14c May 14, 2026 04:01PM
Senti Bio publishes CAR design research in Cell Systems Apr 1, 2026 08:45AM
H.C. Wainwright on Senti Biosciences, Inc. (SNTI): FDA Alignment and Mid-2026 Durability Data in Focus Mar 27, 2026 12:47PM
Senti Biosciences (SNTI) Misses Q4 EPS by 53c Mar 27, 2026 08:08AM
Senti Bio receives FDA advanced therapy designation for leukemia drug Dec 9, 2025 07:02AM


Nov 21, 2025 08:19AM Leerink Partners Starts Senti Biosciences, Inc. (SNTI) at Outperform
Nov 13, 2025 06:47PM Senti Biosciences (SNTI) Misses Q3 EPS by 69c
Oct 14, 2025 06:05AM H.C. Wainwright Starts Senti Biosciences, Inc. (SNTI) at Buy
Aug 7, 2025 09:45AM Senti Biosciences (SNTI) Misses Q2 EPS by 56c
Jul 22, 2025 08:40AM JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live
Jun 18, 2025 07:01AM Senti Biosciences (SNTI) Granted U.S. FDA Orphan Drug Designation for Use of First-in-Class Off-the-Shelf Logic Gated Selective CD33 OR FLT3 NOT EMCN CAR NK Cell Therapy, SENTI-202
Jun 6, 2025 12:15AM Laidlaw Starts Senti Biosciences, Inc. (SNTI) at Buy
May 8, 2025 08:36AM Senti Biosciences (SNTI) Releases Mechanism of Action Video for SENTI-202
May 7, 2025 04:32PM Senti Biosciences (SNTI) Misses Q1 EPS by 141c
Apr 28, 2025 07:03AM Senti Biosciences' (SNTI) SENTI-202 Demonstrates Positive Preliminary Clinical Results in the Treatment of Patients with Relapsed/Refractory AML
Apr 10, 2025 08:45AM Senti Biosciences (SNTI) Appoints James B. Trager to its Scientific Advisory Board
Apr 7, 2025 08:45AM Senti Biosciences (SNTI) Joins Webull Corporate Connect Service Platform
Mar 21, 2025 06:30AM Senti Biosciences (SNTI) Files $300M Mixed Shelf
Mar 20, 2025 05:39PM Senti Biosciences (SNTI) Misses Q4 EPS by 67c
Mar 13, 2025 04:02PM Senti Biosciences (SNTI) appoints Feng Hsiung to Board
Feb 25, 2025 08:02AM Senti Biosciences (SNTI) Strengthens Leadership Team with Strategic Hires
Jan 6, 2025 09:00AM Senti Biosciences (SNTI) Announces Additional $11.5M of Financing
Dec 4, 2024 06:54AM Senti Biosciences, Inc. (SNTI) PT Raised to $12 at Chardan Capital Markets
Dec 2, 2024 10:04AM Senti Biosciences (SNTI) Halted on Volatility, Now Up 493%
Dec 2, 2024 07:11AM Senti Biosciences (SNTI) Announces Oversubscribed $37.6 Million Private Placement Equity Financing
Dec 2, 2024 07:02AM Senti Biosciences (SNTI) Announces Positive Initial Clinical Data in Phase 1 Clinical Trial of SENTI-202
Dec 2, 2024 07:01AM Senti Biosciences (SNTI) Appoints Fran Schulz to its Board
Jul 16, 2024 08:31AM Senti Biosciences (SNTI) Announces 1-for-10 Reverse Stock Split
Jul 1, 2024 08:07AM Senti Biosciences (SNTI) Awarded California Institute for Regenerative Medicines (CIRM) Grant for Clinical Development of Logic Gated CAR-NK Cell Therapy